Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kenneth Cusi
University of Florida, Department: Md Endocrinology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Novo Nordisk
I am advising the company in a phase 2b clinical trial of semaglutide. This agent is not approved yet by the FDA but may be in late 2017 for the treatment of type 2 diabetes. My advise is about its potential to treat fatty liver disease (T2DM) and not diabetes itself. They may pursue an indication and do a large phase 3 study if preliminary phase 2 data promising. I am helping in trial development and education in fertilizer disease.
There will be one consulting meeting in the United States (1 day) and another in Germany (2 days with travel), having been invited to advise and educate at both meetings.
Filed on October 10, 2016.
Tell us what you know about Kenneth Cusi's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Kenneth Cusi”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kenneth Cusi | University of Florida | Financial Disclosure | Prosciento | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Janssen Pharmaceutical | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Poxel | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Chronic Liver Disease Foundation | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Allergan, Inc. | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Novo Nordisk | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Bristol-Myers Squibb Company (BMS) | |
| Kenneth Cusi | University of Florida | Financial Disclosure | DeuteRx | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Merck |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.